The Rise of Hyperpalatability
Published on April 2, 2025 8:18 PM GMT Hello, this is my first post here. I was told by a friend that I should post here. This is from a series of works that I wrote with strict structural requirements. I have performed minor edits to make the essay more palatable for human consumption. This […]
The Truth About Weight Loss After 40
(Note: Thank you for supporting businesses like the one presenting a sponsored message below and working with them through the links below which benefits Gateway Pundit. We appreciate your support!) The game is rigged. No matter what combination of diet and exercise you try, losing weight is a losing battle. Nearly 75% of Americans are […]
GLP-1 Drugs Reshape U.S. Weight Loss Industry – $2 Billion Shift from Commercial Firms – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “U.S. Weight Loss & Diet Control Market: Commercial (non-medical) Programs & Products” report from Marketdata LLC has been added to ResearchAndMarkets.com’s offering. The $38 billion U.S. commercial weight loss market is 15% larger than in 2020, but has had to pivot to adjust to huge competition from the popular GLP-1 drugs. The large […]
Compounded GLP-1s Helped Them Lose Weight, But New FDA Rule Could Block Access
The FDA’s new rule restricting the sale of compounded semaglutide could make it more difficult for some people to obtain affordable weight loss medications. Images Provided by Bailey Fields and Todd Kennedy. A new restriction on the sale of compounded weight loss drugs containing the active ingredient semaglutide is scheduled to take effect in about […]
The Good Bug launches ‘natural’ weight loss solution amid GLP-1 drug debate
The startup claims that, unlike injectable drugs such as Ozempic and Mounjaro, which can have side effects, its solution is a non-invasive formula that naturally boosts the GLP-1 hormone level to suppress appetite and support metabolism.
‘GLP-1-boosting’ supplement launched as drug alternative
What happens to weight when you come off GLP-1 drugs? It can be regained, but a new supplement claims to be an alternative in the market
Prolonged signaling of backbone-modified glucagon‐like peptide‐1 analogues with diverse receptor trafficking
Proceedings of the National Academy of Sciences, Volume 122, Issue 14, April 2025. <br/>SignificanceGlucagon-like peptide-1 (GLP-1) receptor (GLP-1R) agonists are useful for the treatment of type 2 diabetes and obesity. Controlling GLP-1R signaling parameters, including duration and subcellular location, is an important goal for mechanistic …
Rare sugars curb appetite and mimic diabetes drugs in mice
Rare sugars like D-allulose, D-tagatose, and D-sorbose significantly boosted GLP-1 secretion and suppressed food intake in mice. D-allose also reduced food intake through a unique, GLP-1-independent pathway.
HIMS Expands Telehealth Offerings with Eli Lilly’s GLP-1 Drugs
Related Stocks: HIMS,
GLP-1 spending hits $5.8B for adults without diabetes
A new study found that spending on GLP-1 medications such as Ozempic, Wegovy and Zepbound surged to $5.8 billion in 2022 among U.S. adults without diabetes. The research, published April 1 in the Annals of Internal Medicine, showed the number of non-diabetic adults using these drugs — which are also prescribed for weight loss — […]